These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25936739)

  • 21. A pragmatic real-life study of flash glucose monitoring versus self-monitoring of blood glucose.
    Greve SV; Stilgren L
    Dan Med J; 2020 Jun; 67(6):. PubMed ID: 32741434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucometer use and glycemic control among Hispanic patients with diabetes in southern Florida.
    Kenya S; Lebron C; Reyes Arrechea E; Li H
    Clin Ther; 2014 Apr; 36(4):485-93. PubMed ID: 24731865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical use of continuous glucose monitoring system in gestational diabetes mellitus and type 2 diabetes complicated with pregnancy].
    Song Y; Yang H
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):579-83. PubMed ID: 25354857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial.
    Parsons S; Luzio S; Bain S; Harvey J; McKenna J; Khan A; Rice S; Watkins A; Owens DR
    BMC Endocr Disord; 2017 Jan; 17(1):4. PubMed ID: 28143495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomised controlled trial.
    Warren R; Carlisle K; Mihala G; Scuffham PA
    J Telemed Telecare; 2018 Oct; 24(9):586-595. PubMed ID: 28814128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Association Between HbA
    Seyed Ahmadi S; Westman K; Pivodic A; Ólafsdóttir AF; Dahlqvist S; Hirsch IB; Hellman J; Ekelund M; Heise T; Polonsky W; Wijkman M; Schwarcz E; Lind M
    Diabetes Care; 2020 Sep; 43(9):2017-2024. PubMed ID: 32641374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of a Smartphone-Based, Patient-Centered Diabetes Care System in Patients With Type 2 Diabetes: A Randomized, Controlled Trial for 24 Weeks.
    Kim EK; Kwak SH; Jung HS; Koo BK; Moon MK; Lim S; Jang HC; Park KS; Cho YM
    Diabetes Care; 2019 Jan; 42(1):3-9. PubMed ID: 30377185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of a community health workers-led structured program on blood glucose control among latinos with type 2 diabetes: the DIALBEST trial.
    Pérez-Escamilla R; Damio G; Chhabra J; Fernandez ML; Segura-Pérez S; Vega-López S; Kollannor-Samuel G; Calle M; Shebl FM; D'Agostino D
    Diabetes Care; 2015 Feb; 38(2):197-205. PubMed ID: 25125508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.
    Rosenstock J; Wysham C; Frías JP; Kaneko S; Lee CJ; Fernández Landó L; Mao H; Cui X; Karanikas CA; Thieu VT
    Lancet; 2021 Jul; 398(10295):143-155. PubMed ID: 34186022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT.
    Khunti K; Griffin S; Brennan A; Dallosso H; Davies M; Eborall H; Edwardson C; Gray L; Hardeman W; Heathcote L; Henson J; Morton K; Pollard D; Sharp S; Sutton S; Troughton J; Yates T
    Health Technol Assess; 2021 Dec; 25(77):1-190. PubMed ID: 34995176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A carbohydrate-reduced high-protein diet improves HbA
    Skytte MJ; Samkani A; Petersen AD; Thomsen MN; Astrup A; Chabanova E; Frystyk J; Holst JJ; Thomsen HS; Madsbad S; Larsen TM; Haugaard SB; Krarup T
    Diabetologia; 2019 Nov; 62(11):2066-2078. PubMed ID: 31338545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial.
    Di Molfetta S; Patruno P; Cormio S; Cignarelli A; Paleari R; Mosca A; Lamacchia O; De Cosmo S; Massa M; Natalicchio A; Perrini S; Laviola L; Giorgino F
    J Endocrinol Invest; 2022 Sep; 45(9):1663-1671. PubMed ID: 35476320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a Mobile Phone-Based Glucose-Monitoring and Feedback System for Type 2 Diabetes Management in Multiple Primary Care Clinic Settings: Cluster Randomized Controlled Trial.
    Yang Y; Lee EY; Kim HS; Lee SH; Yoon KH; Cho JH
    JMIR Mhealth Uhealth; 2020 Feb; 8(2):e16266. PubMed ID: 32130172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes.
    Oster G; Sullivan SD; Dalal MR; Kazemi MR; Rojeski M; Wysham CH; Sung J; Johnstone B; Cali AM; Wei LJ; Traylor L; Anhalt H; Hull M; Van Vleet J; Meneghini LF
    Postgrad Med; 2016 Nov; 128(8):731-739. PubMed ID: 27690710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
    Kennedy L; Herman WH; Strange P; Harris A;
    Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
    Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
    Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of structured self-monitoring of blood glucose, with and without additional TeleCare support, on overall glycaemic control in non-insulin treated Type 2 diabetes: the SMBG Study, a 12-month randomized controlled trial.
    Parsons SN; Luzio SD; Harvey JN; Bain SC; Cheung WY; Watkins A; Owens DR
    Diabet Med; 2019 May; 36(5):578-590. PubMed ID: 30653704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: A prospective observational cohort study.
    Bosi E; Gregori G; Cruciani C; Irace C; Pozzilli P; Buzzetti R
    Diabetes Res Clin Pract; 2022 Jan; 183():109172. PubMed ID: 34883185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
    Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
    Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.